Bos JD - Search Results

1

How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review.

Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T. Spuls PI, et al. Among authors: bos jd. J Invest Dermatol. 2010 Apr;130(4):933-43. doi: 10.1038/jid.2009.391. Epub 2009 Dec 31. J Invest Dermatol. 2010. PMID: 20043014 Free article. Review.

2

The course of chronic plaque-type psoriasis in placebo groups of randomized controlled studies.

Spuls PI, Witkamp L, Bossuyt PM, Bos JD. Spuls PI, et al. Among authors: bos jd. Arch Dermatol. 2004 Mar;140(3):338-44; discussion 344. doi: 10.1001/archderm.140.3.338. Arch Dermatol. 2004. PMID: 15023777 Review.

3

The burden of psoriasis is not determined by disease severity only.

Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. Heydendael VM, et al. Among authors: bos jd. J Investig Dermatol Symp Proc. 2004 Mar;9(2):131-5. doi: 10.1111/j.1087-0024.2004.09115.x. J Investig Dermatol Symp Proc. 2004. PMID: 15083779 Free article. Clinical Trial.

4

Topical treatments in psoriasis: today and tomorrow.

Bos JD, Spuls PI. Bos JD, et al. Clin Dermatol. 2008 Sep-Oct;26(5):432-7. doi: 10.1016/j.clindermatol.2007.10.025. Clin Dermatol. 2008. PMID: 18755361 Review.

5

Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.

Lecluse LL, Driessen RJ, Spuls PI, de Jong EM, Stapel SO, van Doorn MB, Bos JD, Wolbink GJ. Lecluse LL, et al. Among authors: bos jd. Arch Dermatol. 2010 Feb;146(2):127-32. doi: 10.1001/archdermatol.2009.347. Arch Dermatol. 2010. PMID: 20157022

6

Etanercept: an overview of dermatologic adverse events.

Lecluse LL, Dowlatshahi EA, Limpens CE, de Rie MA, Bos JD, Spuls PI. Lecluse LL, et al. Among authors: bos jd. Arch Dermatol. 2011 Jan;147(1):79-94. doi: 10.1001/archdermatol.2010.410. Arch Dermatol. 2011. PMID: 21242398 Review.

7

The development of practice guidelines for the treatment of severe plaque form psoriasis.

Spuls PI, Bossuyt PM, van Everdingen JJ, Witkamp L, Bos JD. Spuls PI, et al. Among authors: bos jd. Arch Dermatol. 1998 Dec;134(12):1591-6. doi: 10.1001/archderm.134.12.1591. Arch Dermatol. 1998. PMID: 9875199

8

Initial experience with routine administration of etanercept in psoriasis.

de Groot M, Appelman M, Spuls PI, de Rie MA, Bos JD. de Groot M, et al. Among authors: bos jd. Br J Dermatol. 2006 Oct;155(4):808-14. doi: 10.1111/j.1365-2133.2006.07432.x. Br J Dermatol. 2006. PMID: 16965432

9

A randomized trial of methotrexate versus azathioprine for severe atopic eczema.

Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI. Schram ME, et al. Among authors: bos jd. J Allergy Clin Immunol. 2011 Aug;128(2):353-9. doi: 10.1016/j.jaci.2011.03.024. Epub 2011 Apr 22. J Allergy Clin Immunol. 2011. PMID: 21514637 Clinical Trial.

10

Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis.

Van Leent EJ, Ebelin ME, Burtin P, Dorobek B, Spuls PI, Bos JD. Van Leent EJ, et al. Among authors: bos jd. Dermatology. 2002;204(1):63-8. doi: 10.1159/000051813. Dermatology. 2002. PMID: 11834853 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page